Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Athena SWAN Silver has been awarded to the Department of Psychiatry and the Nuffield Department of Clinical Medicine in recognition of their commitment to advancing women's careers in science and medicine in academia.

Athena SwanThe latest round of awards announced by the Equality Challenge Unit today mean that Departments and units in the Division now hold 4 Silver and 14 Bronze awards.

Professor John Geddes, Head of the Department of Psychiatry, commented upon hearing of the department’s Silver award, “This is an incredibly important step for the Department. It is the result of a great deal of hard work and real change over the last few years, led by Liz Tunbridge and the Athena SWAN Committee and with major effort and engagement from across the Department. We certainly won’t stop here in pursuing greater equality for women and will now start our planning for a Gold award."

Professor Sir Peter Ratcliffe, Head of the Nuffield Department of Clinical Medicine said, “I am absolutely delighted to hear this news. It is an important milestone in our efforts to make Oxford Medicine, and the Department in particular, a destination of choice for ambitious female doctors and biomedical scientists. I am extremely grateful for all the hard work from so many, which has brought about the changes underpinning this Athena SWAN Silver Award.”

The Head of the Medical Sciences Division, Professor Alastair Buchan, remarked, “As a Division we are committed to improving the culture for all our staff and students. These awards recognise the continued effort of our departments to support all their members to achieve their potential.”

Links:

Related story:

Similar stories

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.